Fluonilid

CAS No. 790-69-2

Fluonilid( Loflucarban | NSC 76851 | Fluonid | Loflucarbanum | Fluonilide )

Catalog No. M17597 CAS No. 790-69-2

Loflucarban (Fluonilid) is an antimycotic compound.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 108 In Stock
10MG 174 In Stock
25MG 296 In Stock
50MG 446 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Fluonilid
  • Note
    Research use only, not for human use.
  • Brief Description
    Loflucarban (Fluonilid) is an antimycotic compound.
  • Description
    Loflucarban is an antiinfective drug.
  • In Vitro
    One hundred-and-eighty-six fungi were isolated from one hundred-and-eighty cases diagnosed as otomycosis. They comprise 59 species of 26 genera of moulds, and 2 genera of yeasts. Fluonilid shows the MIC ranged from > 100 μg/ml to 1 μg/ml for the majority of tested fungi.
  • In Vivo
    ——
  • Synonyms
    Loflucarban | NSC 76851 | Fluonid | Loflucarbanum | Fluonilide
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    790-69-2
  • Formula Weight
    315.2
  • Molecular Formula
    C13H9Cl2FN2S
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    c1cc(ccc1NC(=S)Nc1cc(cc(c1)Cl)Cl)F
  • Chemical Name
    1-(3,5-dichlorophenyl)-3-(4-fluorophenyl)thiourea

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.J S Mills, et al. Journal of the American Chemical Society, 80, 3399-3404 (1960)
molnova catalog
related products
  • Desalkylterbuthylazi...

    Used as pharmaceutical intermediates.

  • 4-chlorofuro[3,2-c]p...

    Compound Fr13857 is a useful organic compound for research related to life sciences.

  • OD1

    Potent rat Nav1.7, human Nav1.4 and rat Nav1.6 channel activator (EC50 values are 7, 10 and 47 nM, respectively). Exhibits minimal activation at mammalian Nav1.2, Nav1.3 and Nav1.5 (EC50 values >3 μM). Inhibits fast inactivation on all channels. Increases peak currents at all voltages and stimulates a persistent Na+ current at hNav1.7 channel. Increases hyperpolarization at Nav1.4 and Nav1.6 channels. Induces spontaneous pain in vivo.